News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
159,533 Results
Type
Article (8014)
Company Profile (19)
Press Release (151499)
Multimedia
Podcasts (20)
Webinars (4)
Section
Business (57543)
Career Advice (229)
Deals (10000)
Drug Delivery (41)
Drug Development (18446)
Employer Resources (33)
FDA (3723)
Job Trends (4137)
News (81231)
Policy (6069)
Tag
2027 BioCapital Standard (1)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (2)
Academia (489)
Accelerated approval (21)
ADA (12)
Adcomms (4)
Allergies (63)
Alliances (7109)
ALS (48)
Alzheimer's disease (447)
Antibody-drug conjugate (ADC) (173)
Approvals (4065)
Artificial intelligence (153)
ASCO (86)
Autoimmune disease (114)
Automation (11)
Bankruptcy (62)
Belgium (3)
Best Places to Work (3407)
BIO (35)
Biologics (4)
BIOSECURE Act (2)
Biosimilars (56)
BioSpace Insights (22)
Biotechnology (14)
Bispecific (1)
Bladder cancer (91)
Brain cancer (34)
Breast cancer (288)
Cancer (2155)
Cardiovascular disease (211)
Career advice (198)
Career pathing (8)
CAR-T (87)
CDC (14)
CDMO (34)
Celiac Disease (1)
Cell therapy (237)
Cervical cancer (20)
Clinical research (17989)
Collaboration (428)
Commercialization (3)
Company closure (3)
Compensation (1209)
Complete response letters (19)
COVID-19 (560)
CRISPR (22)
C-suite (449)
Cystic fibrosis (43)
Data (3236)
Denatured (4)
Depression (46)
Dermatology (51)
Diabetes (210)
Diagnostics (1538)
Digital health (15)
Diversity (1)
Diversity, equity & inclusion (6)
Drug discovery (95)
Drug pricing (50)
Drug shortages (10)
Duchenne muscular dystrophy (83)
Earnings (33937)
Editorial (14)
Employer branding (6)
Employer resources (30)
Events (21506)
Executive appointments (390)
FDA (5094)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (7)
Frontotemporal dementia (12)
Funding (518)
Gene editing (52)
Generative AI (14)
Gene therapy (195)
GLP-1 (387)
Government (960)
Grass and pollen (3)
Guidances (317)
Healthcare (4818)
Hematology (62)
HIV (40)
Huntington's disease (10)
IgA nephropathy (63)
Immunology and inflammation (84)
Immuno-oncology (26)
Indications (74)
Infectious disease (672)
Inflammatory bowel disease (59)
Inflation Reduction Act (4)
Influenza (33)
Intellectual property (52)
Interviews (31)
IPO (6116)
IRA (8)
Job creations (869)
Job search strategy (173)
JPM (15)
Kidney cancer (13)
Kidney disease (34)
Labor market (44)
Layoffs (157)
Leadership (4)
Legal (1183)
Licensing (6)
Liver cancer (21)
Longevity (7)
Lung cancer (328)
Lymphoma (212)
Machine learning (10)
Management (12)
Manufacturing (284)
Marketing (1)
MASH (67)
Medical device (3360)
Medtech (3416)
Mergers & acquisitions (4348)
Metabolic disorders (560)
mRNA (51)
Multiple sclerosis (78)
NASH (6)
Netherlands (1)
Neurodegenerative disease (128)
Neuropsychiatric disorders (39)
Neuroscience (915)
NextGen: Class of 2026 (1399)
Non-profit (1030)
Now hiring (7)
Obesity (272)
Opinion (59)
Ovarian cancer (77)
Pain (61)
Pancreatic cancer (96)
Parkinson's disease (113)
Partnered (9)
Patents (114)
Patient recruitment (156)
Patient selection (3)
Peanut (23)
People (12549)
Peptides (2)
Pharmaceutical (3)
Pharmacy benefit managers (4)
Phase 1 (4503)
Phase 2 (7699)
Phase 3 (7179)
Pipeline (4676)
Policy (59)
Postmarket research (670)
Preclinical (1329)
Press Release (6)
Prostate cancer (91)
Psychedelics (18)
Radiopharmaceuticals (96)
Rare diseases (374)
Real estate (1086)
Recruiting (15)
Regenerative medicine (3)
Regulatory (5610)
Reports (25)
Research institute (475)
Resumes & cover letters (43)
Rett syndrome (10)
RNA editing (7)
RSV (26)
Schizophrenia (54)
Series A (77)
Series B (42)
Service/supplier (1)
Sickle cell disease (36)
Special edition (15)
Spinal muscular atrophy (70)
Sponsored (15)
Startups (752)
Stomach cancer (5)
Substance use disorders (6)
Supply chain (27)
Tariffs (35)
The Weekly (16)
Vaccines (295)
Venture capital (32)
Weight loss (197)
Women's health (33)
Worklife (5)
Date
Last 7 days (151)
Last 30 days (568)
Last 365 days (9504)
2026 (6824)
2025 (9694)
2024 (9745)
2023 (10588)
2022 (12184)
2021 (13149)
2020 (11906)
2019 (10953)
2018 (8158)
2017 (7247)
2016 (6574)
2015 (7741)
2014 (5592)
2013 (4548)
2012 (4700)
2011 (4942)
2010 (4247)
Location
Africa (164)
Alabama (21)
Alaska (1)
Arizona (64)
Arkansas (2)
Asia (9238)
Australia (1464)
California (4567)
Canada (1387)
China (484)
Colorado (164)
Connecticut (194)
Delaware (201)
Europe (23246)
Florida (584)
Georgia (126)
Hawaii (2)
Idaho (9)
Illinois (310)
India (33)
Indiana (349)
Iowa (2)
Japan (244)
Kansas (43)
Kentucky (9)
Louisiana (21)
Maine (28)
Maryland (562)
Massachusetts (3195)
Michigan (103)
Minnesota (201)
Mississippi (1)
Missouri (39)
Montana (10)
Nebraska (5)
Nevada (43)
New Hampshire (31)
New Jersey (1410)
New Mexico (3)
New York (1233)
North Carolina (535)
North Dakota (2)
Northern California (2426)
Ohio (87)
Oklahoma (3)
Oregon (6)
Pennsylvania (924)
Puerto Rico (5)
Rhode Island (4)
South America (258)
South Carolina (18)
Southern California (1862)
Tennessee (68)
Texas (728)
United States (16030)
Utah (129)
Virginia (100)
Washington D.C. (11)
Washington State (334)
West Virginia (2)
Wisconsin (30)
159,533 Results for "25".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Edesa Biotech Announces Pricing of $25.0 Million Public Offering
August 20, 2026
·
6 min read
Press Releases
CORRECTING and REPLACING Agilent Announces Cash Dividend of 25.5 Cents per Share
September 17, 2026
·
2 min read
Press Releases
Agilent Announces Cash Dividend of 25.5 Cents per Share - September 16, 2026
September 17, 2026
·
1 min read
Press Releases
The Princess Margaret Cancer Foundation Launches Historic $2.5 Billion Carry The Fire Campaign
September 23, 2026
·
4 min read
Press Releases
Ramona Optics Raises $25 Million Series A to Transform Biomedical Research with Massively Parallel Microscopy
September 22, 2026
·
4 min read
Press Releases
Arintra Raises $25M to Pioneer Revenue Assurance for America’s Health Systems
August 26, 2026
·
7 min read
China
Lilly sets aside up to $3.25B to tackle critical unmet need targets with InnoCare
InnoCare Pharma is the latest addition to Eli Lilly’s dealmaking spree, which includes some of the biggest acquisitions this year: up to $7 billion for Kelonia Therapeutics in April and up to $7.8 billion for Centessa Pharmaceuticals in March.
September 24, 2026
·
1 min read
·
Tristan Manalac
Press Releases
Kaiser Permanente commits $25 million to Martin Luther King Jr. Community Hospital
August 11, 2026
·
5 min read
Press Releases
Tempo Therapeutics Awarded $2.25 Million NIH SBIR Grant to Advance MAP™ Technology for Complex Wound Healing
September 23, 2026
·
4 min read
Press Releases
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - August 25, 2026
August 25, 2026
·
1 min read
1 of 15,954
Next
